Nemaura Medical Inc.: Nasdaq/NYSE listing notice — Nemaura Medical receives Nasdaq deficiency notices for MVLS and bid price; 180-day cure periods

Nemaura Medical Inc.

On April 3, 2023, Nasdaq notified Nemaura of noncompliance with $35M minimum market value of listed securities rule.
On April 7, 2023, Nasdaq notified Nemaura of noncompliance with $1.00 minimum bid price requirement.
Company has 180 calendar days (until October 2/3, 2023) to regain compliance on each deficiency.
Deficiencies have no immediate effect on listing or trading of NMRD common stock on Nasdaq.
Company is evaluating alternatives but no decisions made; compliance not assured.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Nemaura Medical Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 7, 2023, the Company received written notice (the “Bid Price Notice”) from the Nasdaq Staff indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market under the symbol “NMRD,” and the Company is currently monitoring the closing bid price of its common stock and evaluating its alternatives, if appropriate, to resolve th

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Nemaura Medical Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

April 3, 2023, Nemaura Medical Inc. (the “Company”) received a written notice (the “MVLS Notice”) from the Nasdaq Listing Qualification Department (the “Nasdaq Staff”) indicating that the Company is not in compliance with the $35 million minimum market value of listed securities requirement set forth in Nasdaq Listing Rule 5550(b)(2) for continued listing on the Nasdaq Capital Market. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market under the symbol “NMRD,” and the Company is currently monitoring the

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001079973-23-000460

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.